Synapse version 3.1 from Fujifilm Medical Systems USA features advances in data processing and presentation, extended dictation support, and DICOM query and retrieve functionality. Interaction with PACS made by other vendors is one of the highlights of the new software.
Synapse version 3.1 from Fujifilm Medical Systems USA features advances in data processing and presentation, extended dictation support, and DICOM query and retrieve functionality. Interaction with PACS made by other vendors is one of the highlights of the new software.
An enhanced Reading Protocols function, Clinical Conferencing and Series Renaming, saves the presentation of past series and changes series names, when necessary, to make them more consistent and, therefore, easier to find and review. The "save" function eliminates the need to rearrange and navigate through images when revisiting a past study as part of a later collaboration or conference. The renaming feature further streamlines the diagnostic process.
Fuji's new DICOM SCU (service class user) makes other PACS behave as if they were Synapse PACS by mapping the information contained in these systems into the Synapse infrastructure, allowing their images to be viewed using Synapse tools. This permits Synapse to be at the core of a multisite PACS implementation or operate within a multi-PACS site.
Version 3.1 also extends Synapse's breadth of integration options for dictation systems. Supported vendors now include G2 Speech, Lanier Serial Port, Powerscribe, Provox, Quadrat Speech Technology, and Talk Technology.
Fuji plans to release new software version commercially in the first quarter of 2005. Fuji's RSNA booth also features a work-in-progress being developed to port image optimization algorithms from computed radiography to volume-based exams, such as multislice CT.
Dynamic Range Control and Image Sharpening, which enhance and sharpen the borders of tissues with different densities, such as bone and soft tissue, are key components of the work-in-progress, which promises to improve diagnostic certainty in the interpretation of CT studies.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.